BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23928440)

  • 1. Salivary thiol levels and periodontal parameters assessed with a chromogenic strip.
    Khocht A; Seyedain M; Hardan S; Gaughan J; Suzuki JB
    Gen Dent; 2013 Aug; 61(5):50-4. PubMed ID: 23928440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of salivary procalcitonin levels in different periodontal diseases.
    Hendek MK; Erdemir EO; Kisa U
    J Periodontol; 2015 Jun; 86(6):820-6. PubMed ID: 25703733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of smoking on interleukin-1beta level, oxidant status and antioxidant status in gingival crevicular fluid from chronic periodontitis patients before and after periodontal treatment.
    Toker H; Akpınar A; Aydın H; Poyraz O
    J Periodontal Res; 2012 Oct; 47(5):572-7. PubMed ID: 22364664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary antioxidants as periodontal biomarkers in evaluation of tissue status and treatment outcome.
    Novakovic N; Todorovic T; Rakic M; Milinkovic I; Dozic I; Jankovic S; Aleksic Z; Cakic S
    J Periodontal Res; 2014 Feb; 49(1):129-36. PubMed ID: 23710550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-glucuronidase activity in saliva: relationship to clinical periodontal parameters.
    Lamster IB; Kaufman E; Grbic JT; Winston LJ; Singer RE
    J Periodontol; 2003 Mar; 74(3):353-9. PubMed ID: 12710755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between gingival crevicular fluid TGF-beta1 levels and periodontal status in HIV-1(+) patients.
    Alpagot T; Konopka K; Bhattacharyya M; Gebremedhin S; Düzgüneş N
    J Periodontol; 2008 Jan; 79(1):123-30. PubMed ID: 18166101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary antioxidants in patients with type 1 or 2 diabetes and inflammatory periodontal disease: a case-control study.
    Gümüş P; Buduneli N; Cetinkalp S; Hawkins SI; Renaud D; Kinane DF; Scott DA
    J Periodontol; 2009 Sep; 80(9):1440-6. PubMed ID: 19722794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saliva and serum levels of B-cell activating factors and tumor necrosis factor-α in patients with periodontitis.
    Gümüş P; Nizam N; Lappin DF; Buduneli N
    J Periodontol; 2014 Feb; 85(2):270-80. PubMed ID: 23701482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of salivary lactoferrin, a marker for chronic periodontitis?
    Glimvall P; Wickström C; Jansson H
    J Periodontal Res; 2012 Oct; 47(5):655-60. PubMed ID: 22471324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of periodontal status and periodontopathogens on levels of oral human β-defensin-2 in saliva.
    Pereira AL; Franco GC; Cortelli SC; Aquino DR; Costa FO; Raslan SA; Cortelli JR
    J Periodontol; 2013 Oct; 84(10):1445-53. PubMed ID: 23173827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactoferrin levels in gingival crevicular fluid and saliva of HIV-infected patients with chronic periodontitis.
    Ferreira SM; Gonçalves LS; Torres SR; Nogueira SA; Meiller TF
    J Investig Clin Dent; 2015 Feb; 6(1):16-24. PubMed ID: 25331852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gingival crevicular fluid osteopontin levels in periodontal health and disease.
    Sharma CG; Pradeep AR
    J Periodontol; 2006 Oct; 77(10):1674-80. PubMed ID: 17032109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary visfatin concentrations in patients with chronic periodontitis.
    Tabari ZA; Azadmehr A; Nohekhan A; Naddafpour N; Ghaedi FB
    J Periodontol; 2014 Aug; 85(8):1081-5. PubMed ID: 24228809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis.
    Mayer Y; Balbir-Gurman A; Machtei EE
    J Periodontol; 2009 Sep; 80(9):1414-20. PubMed ID: 19722791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary interleukin-1β levels in patients with chronic periodontitis before and after periodontal phase I therapy and healthy controls: a case-control study.
    Kaushik R; Yeltiwar RK; Pushpanshu K
    J Periodontol; 2011 Sep; 82(9):1353-9. PubMed ID: 21235331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary-soluble CD44 levels in smokers and non-smokers with chronic periodontitis: a pilot study.
    Ghallab N; Shaker O
    J Periodontol; 2010 May; 81(5):710-7. PubMed ID: 20429650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis.
    Tsai CC; Chen HS; Chen SL; Ho YP; Ho KY; Wu YM; Hung CC
    J Periodontal Res; 2005 Oct; 40(5):378-84. PubMed ID: 16105090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between passive smoking and salivary markers related to periodontitis.
    Nishida N; Yamamoto Y; Tanaka M; Maeda K; Kataoka K; Nakayama K; Morimoto K; Shizukuishi S
    J Clin Periodontol; 2006 Oct; 33(10):717-23. PubMed ID: 16889628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of salivary levels of mucin and amylase in chronic periodontitis patients.
    Sánchez GA; Miozza V; Delgado A; Busch L
    J Periodontal Res; 2011 Apr; 46(2):221-7. PubMed ID: 21143482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary infectious agents and periodontal disease status.
    Saygun I; Nizam N; Keskiner I; Bal V; Kubar A; Açıkel C; Serdar M; Slots J
    J Periodontal Res; 2011 Apr; 46(2):235-9. PubMed ID: 21261620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.